Comparison of the new three dimensional “3D” with the conventional two dimensional “2D” endoscopic camera in surgery of the paranasal sinuses

ISRCTN ISRCTN10446213
DOI https://doi.org/10.1186/ISRCTN10446213
Secondary identifying numbers BASEC Nr 2018-0005
Submission date
14/04/2018
Registration date
26/04/2018
Last edited
31/12/2020
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
Chronic rhinosinusitis is a common disease in which the cavities around the nasal passages become swollen. This may lead to a significant impairment of the quality of life in individuals suffering from the disorder. Medical therapy is the treatment of choice to reduce the symptoms. In severe disease, however, medical therapy may not be sufficient to control the disease activity and symptoms. In these cases, surgical therapy is indicated. The principle of surgical therapy is to open the narrow and blocked drainage pathways of the nasal sinuses and therefore to restore clearance of mucus and widen the access for medical treatment such as sprays. This procedure is known as “Functional Endoscopic Sinus Surgery” (FESS). Modern technology helps reduce the potential risks of FESS such as injury of the eye, the optic nerve, the important carotid artery and the brain which are neighbouring the paranasal sinuses. A key component of this endoscopic surgery of the paranasal sinuses is the long thin flexible tube, with a light source (endoscope) and camera which enables a good visualisation of the surgical area. The actual standard technique of endoscopic visualisation is using endoscopes combined with a high resolution camera, providing a 2-dimensional (2D) picture on a high resolution screen. A new development is recently commercially available providing a 3-dimensional picture, which gives additional information of “depth” in the surgical field. The visualisation of a 3-dimensional surgical field has the potential advantage to provide the surgeon with more realistic information about the anatomy of the surgical field which may be beneficial for surgical control and even reducing complications.
This study aims to compare the standard 2D-endoscopic surgical technique with the new commercially available 3D-endoscopic technique.

Who can participate?
Adult aged 18 years or above with chronic rhinosinusitis

What does the study involve?
As participant of the study, a standard sinus surgery procedure is performed, as indicated for the treatment of the chronic rhinosinusitis, one side with the 2D endoscope, the other with the 3D endoscope. The time taken for each side is measured, as well as the subjective impression of the surgeon using the endoscopes.

What are the possible benefits and risks of participating?
There are no additional risks or benefits for the participants involved in this study
Where is the study run from?
1. ORL-Zentrum Klinik Hirslanden (Switzerland)
2. HNO-Universitätsklinik Ulm (Germany)
3. HNO-Klinik München Bogenhausen (Germany)
4. HNO-Universitätsklinik Graz (Austria)

When is the study starting and how long is it expected to run for?
January 2018 to December 2018

Who is funding the study?
ORL-Zentrum Klinik Hirslanden (Switzerland)

Who is the main contact?
Dr Hans Rudolf Briner (Scientific)

Contact information

Dr Hans Rudolf Briner
Scientific

ORL-Zentrum Klinik Hirslanden
Witellikerstrasse 40
Zurich
CH-8032
Switzerland

Study information

Study designInternational multicentre prospective randomized interventional study
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet ISRCTN10446213_PIS_23Apr18.docx
Scientific titleComparison of 3D Endoscopy with 2D Endoscopy during functional endoscopic sinus surgery
Study objectivesThis study aims to compare the standard 2D-endoscopic surgical technique with the new commercially available 3D-endoscopic technique.
Ethics approval(s)Kantonale Ethikkommission Zürich Ch-8090 Zurich Switzerland, 05/04/2018, ref: 2018-00005
Health condition(s) or problem(s) studiedChronic rhinosinusitis
InterventionA total of 80 patients with chronic rhinosinusitis are evaluated. A Functional endoscopic sinus surgery (FESS) procedure is performed. All participants receive the 2D-endoscopic technique on one side, and 3D-endioscopic technique on the other side. In the first of the 20 patients, the side which is operated by the 2D-endoscope is determined by hazard (Los). In the further patients, the side is alternated after each patient.
There are four individual rhinosurgeons at four centers operating and evaluating 20 patients each.
The centers are Graz (Prof. V. Tomazic), Austria, Munich (Prof. A. Leunig), Germany, Ulm (PD Dr. F. Sommer), Germany and Zurich (KD Dr. H.R. Briner), Switzerland.
There is only the measurement of time of the procedure using the 2D and the 3D camera on each side during the procedure which is performed. Additionally, a questionnaire is filled by the surgeon asking for subjective impressions using the 2D or 3D camera. This questionnaire is designed for this study in order to look for subjective differences of the camera techniques. There is no follow up for the study after the procedure.
Intervention typeDevice
Pharmaceutical study type(s)
Phase
Drug / device / biological / vaccine name(s)
Primary outcome measureTime of procedure is measured for 2D and 3D techniques during FESS procedure
Secondary outcome measuresThe impressions of the surgeon on both 2D and 3D techniques are measured using a structured surgeon’s questionnaire at the end of the procedure.
Overall study start date01/01/2018
Completion date31/01/2020

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants80; 20 at each of the four study centres
Total final enrolment80
Key inclusion criteria1. Adult aged 18 years or above
2. Chronic rhinosinusitis
3. Candidate for endoscopic sinus surgery
Key exclusion criteria1. Age below 18 years
2. Previous sinus operations
3. Unilateral or asymmetric disease
4. Severe comorbidities such as bleeding disorders
5. Inability or unwillingness to give consent for the study
Date of first enrolment15/02/2019
Date of final enrolment11/12/2019

Locations

Countries of recruitment

  • Austria
  • Germany
  • Switzerland

Study participating centres

ORL-Zentrum Klinik Hirslanden
Witellikerstrasse 40
Zurich
Ch-8032
Switzerland
HNO-Universitätsklinik Ulm
Frauensteige 12
Ulm
89075
Germany
HNO-Klinik München Bogenhausen
Dr. Gaertner GmbH
Possartstrasse 27-31
München
8169
Germany
HNO-Universitätsklinik Graz
Auenbruggerplatz 1
Graz
8036
Austria

Sponsor information

ORL-Zentrum Klinik Hirslanden
Hospital/treatment centre

Witellikerstrasse 40
Zurich
CH-8032
Switzerland

Phone +41 44 387 28 00
Email briner@orl-Zentrum.com
ROR logo "ROR" https://ror.org/014c2qb55

Funders

Funder type

Hospital/treatment centre

ORL-Zentrum Klinik Hirslanden

No information available

Results and Publications

Intention to publish date31/01/2021
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot expected to be made available
Publication and dissemination planPlanned publication in a high-impact peer reviewed journal.
IPD sharing planThe datasets generated during and/or analysed during the current study are not expected to be made available.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet 23/04/2018 01/04/2019 No Yes
Protocol file 23/04/2018 01/04/2019 No No
Results article results 29/12/2020 31/12/2020 Yes No

Additional files

ISRCTN10446213_PIS_23Apr18.docx
Uploaded 01/04/2019
ISRCTN10446213_protocol_23Apr18.pdf
Uploaded 01/04/2019

Editorial Notes

31/12/2020: Publication reference added.
08/01/2020: The total final enrolment number has been added.
12/12/2019: The recruitment end date was changed from 30/11/2019 to 11/12/2019.
06/12/2019: The total final enrolment number has been added.
14/11/2019: The following changes have been made:
1. The recruitment end date has been changed from 31/10/2019 to 30/11/2019.
2. The overall trial end date has been changed from 31/12/2019 to 31/01/2020.
3. The intention to publish date has been changed from 01/12/2020 to 31/01/2021.
05/09/2019: The recruitment end date has been changed from 30/08/2019 to 31/10/2019.
01/04/2019: The participant information sheet and protocol (not peer reviewed) have been uploaded.
10/01/2019: The following changes have been made:
1. The recruitment start date has been updated from 01/05/2018 to 15/02/2019.
2. The recruitment end date has been updated from 01/12/2018 to 30/08/2019.
3. The overall trial end date has been updated from 31/12/2018 to 31/12/2019.
4. The intention to publish date has been updated from 30/06/2019 to 01/12/2020.